In the Lab Megan Molteni In world’s first genetically engineered marsupials, scientists get a fresh window into human biology
Biotech Damian Garde STAT Plus: With genome-editing companies’ stock booming, Beam Therapeutics seizes its moment
Biotech Adam Feuerstein STAT Plus: First attempt at genome editing in U.S. patients produces disappointing — and sobering — results
In the Lab Sharon Begley Do CRISPR enthusiasts have their head in the sand about the safety of gene editing?
In the Lab Sharon Begley Clash of scientific titans: CRISPR hits the courts, with money and prestige at stake